1-6 of 6
Fenghuang Zhan, PhD
Close
Sort by
Journal Articles

Changes in the Expression of Proteasome Genes in Tumor Cells Following Short-Term Proteasome Inhibitor Therapy Predicts Survival in Multiple Myeloma Treated with Bortezomib-Containing Multi-Agent Chemotherapy

John D. Shaughnessy, Jr., PhD, Pingping Qu, MD, Ricky Edmondson, PhD, Damir Herman, PhD, Yiming Zhou, PhD, Erming Tian, Frits van Rhee, MD, PhD, Mauricio Pineda-Roman, MD, PhD, Yazan Alsayed, Elias Anaissie, Ya-wei Qiang, Joshua Epstein, PhD, Shmuel Yaccoby, PhD, David Williams, Fenghuang Zhan, PhD, Owen Stephens, Antje Hoering, PhD, John Crowley, PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 733.
https://doi.org/10.1182/blood.V112.11.733.733
Published: 2008
Journal Articles

The Transcriptome of Multiple Myeloma (MM) Defines Disease Subgroups with Distinct Genetic and Clinical Features.

Fenghuang Zhan, PhD, Bart Barlogie, MD, PhD, Yongsheng Huang, PhD, Eric Rasmussen, Jeffrey Sawyer, M. Santra, Ronald Walker, MD, Guido Tricot, MD, PhD, John Crowley, Elias Anaissie, MD, John Shaughnessy, PhD
Journal: Blood
Blood (2004) 104 (11): 76.
https://doi.org/10.1182/blood.V104.11.76.76
Published: 2004
Journal Articles

Fibroblast Activation Protein (FAP) Is a Critical Microenvironmental Survival Factor for Myeloma Plasma Cells.

Yun Ge, PhD, Fenghuang Zhan, PhD, John Shaughnessy, PhD, Bart Barlogie, MD, Guido Tricot, MD, Joshua Epstein, DSc, Shmuel Yaccoby, PhD
Journal: Blood
Blood (2004) 104 (11): 634.
https://doi.org/10.1182/blood.V104.11.634.634
Published: 2004
Journal Articles

Serial Gene Expression Studies of Malignant Plasma Cells before Treatment and after Relapse: Identifying Genes Linked to Drug Resistance in Myeloma.

Fenghuang Zhan, PhD, Sisi Kapp, Y. Huang, PhD, Elias J. Anassie, H. Xu, I. Hanamura, Jeffrey Sawyer, M. Santra4, Choon-Kee Lee, MD, Athanasios Fassas, MD, Frits van Rhee, MD, PhD, Klaus Hollmig, MD, Giampaulo Talamo, MD, Raymond Thertulien, MD, Guido Tricot, MD, PhD, William Barlow, Erik Rasmussen, John Crowley, PhD, Bart Barlogie, MD, PhD, John Shaughnessy, PhD
Journal: Blood
Blood (2004) 104 (11): 784.
https://doi.org/10.1182/blood.V104.11.784.784
Published: 2004
Journal Articles

Comprehensive Genome-Wide Profile of Regional Gains and Losses in Multiple Myeloma Using Array-CGH: The 1q21 Amplification and Potential Role of the BCL-9 Gene in Multiple Myeloma Pathogenesis.

Ruben Carrasco, MD., PHD., Giovanni Tonon, MD., PHD., Cameron Brennan, MD, Alexei Protopopov, PHD, Raktim Sinha, BS, Bin Feng, PHD, Christopher Leo, PHD, Yunyu Zhang, MD, Jean Zhang, MS, Fenghuang Zhan, PHD, Marina Protopopova, PHD, Constantine Mitsiades, MD., Nikhil Munshi, MD, Lynda Chin, MD, Peter Bergsagel, MD, Michael Kuehl, MD, John Shaughnessy, MD, Kenneth Anderson, MD, Ronald DePinho, MD
Journal: Blood
Blood (2004) 104 (11): 785.
https://doi.org/10.1182/blood.V104.11.785.785
Published: 2004
Journal Articles

Soluble and Membrane Bound MICA in Myeloma Do Not Adversely Effect Regulation of Natural Killer Cell Function Via NKG2D..

Jumei Shi, MD, PhD, Susann Szmania, BS, Fenghuang Zhan, PhD, John Shaughnessy, PhD, Bart Barlogie, MD, PhD, Guido Tricot, MD, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2462.
https://doi.org/10.1182/blood.V104.11.2462.2462
Published: 2004